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ARTICLE
Differentiation of primate primordial germ cell-like
cells following transplantation into the adult
gonadal niche
Enrique Sosa1, Di Chen1, Ernesto J. Rojas1, Jon D. Hennebold2,3, Karen A. Peters4, Zhuang Wu5, Truong N. Lam5,
Jennifer M. Mitchell6, Meena Sukhwani4, Ramesh C. Tailor7, Marvin L. Meistrich5, Kyle E. Orwig4,
Gunapala Shetty5 & Amander T. Clark 1
A major challenge in stem cell differentiation is the availability of bioassays to prove cell
types generated in vitro are equivalent to cells in vivo. In the mouse, differentiation of
primordial germ cell-like cells (PGCLCs) from pluripotent cells was validated by transplan-
tation, leading to the generation of spermatogenesis and to the birth of offspring. Here we
report the use of xenotransplantation (monkey to mouse) and homologous transplantation
(monkey to monkey) to validate our in vitro protocol for differentiating male rhesus (r)
macaque PGCLCs (rPGCLCs) from induced pluripotent stem cells (riPSCs). Specifically,
transplantation of aggregates containing rPGCLCs into mouse and nonhuman primate tes-
ticles overcomes a major bottleneck in rPGCLC differentiation. These findings suggest that
immature rPGCLCs once transplanted into an adult gonadal niche commit to differentiate
towards late rPGCs that initiate epigenetic reprogramming but do not complete the con-
version into ENO2-positive spermatogonia.
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Germline cells are essential for fertility and passing DNAfrom one generation to the next. In each generation, germcell development begins around the time of embryo
implantation with the differentiation of founding progenitors
called primordial germ cells (PGCs). PGCs are transient and in
the appropriate environment will subsequently advance in dif-
ferentiation towards oogonia in females and pro-spermatogonia
in males. In an inappropriate environment, however, the latent
pluripotency program can be reactivated leading to germ cell
tumors including teratomas. Moreover, the abnormal specifica-
tion of PGCs has the potential to impact the quality of the entire
cohort of germ cells in the adult gonad given that after PGC
specification no other cell type can contribute to the germline.
Therefore, understanding the biology of PGCs has important
implications for future reproductive success and child health.
One of the most exciting models for understanding human
PGC development is the pluripotent stem cell model and differ-
entiation into PGC-like cells (PGCLCs) in vitro1–5. Directed
differentiation protocols for generating human PGCLCs
(hPGCLCs) result in the formation of so-called early PGCs which
are equivalent to PGCs at around week 3 of human embryo
development. Early PGCs in the primate cynomolgus (cyno)
macaque are triple positive for SOX17, PRDM1, and TFAP2C,
while being negative for the late stage PGC markers VASA and
DAZL6. A recent study has demonstrated that female human
embryonic stem cell (hESCs) can differentiate into VASA-positive
human oocyte-like cells7. However, an approach for differ-
entiating male primate PGCLCs into more advanced VASA
positive stages is lacking.
Advanced differentiation and generation of fertilization com-
petent sperm from mouse PGCLCs (mPGCLCs) was first shown
by transplantation of mouse aggregates and mPGCLCs into the
testicles of infertile male mice8–10. Furthermore, mPGCLCs have
been differentiated entirely in vitro using co-culture with gonadal
somatic cells11. The differentiation of male mPGCLCs entirely
in vitro depended first upon the success of testicular transplan-
tation to prove mPGCLC competency. In humans, transplanting
hPGCLCs into the testicles of human subjects as a first-line
experiment to prove hPGCLC competency is inconceivable.
Instead, we propose that a first approach could instead utilize the
testicular xenotransplantation bioassay or alternatively homo-
logous transplantation of nonhuman primate PGCLCs.
Testicular xenotransplantation involves transplantation of
primate (human or nonhuman) testicular cells containing germ
cells into the seminiferous tubules of busulfan-treated or irra-
diated immune-deficient nude mice12–16. More recently, it was
also shown that rhesus macaque PGCs (rPGCs) and human
PGCs (hPGCs) can also persist and form colonies at the basement
membrane of this model, indicating that the testicular xeno-
transplantation approach can be extended to characterize less
mature germline cells, and possibly PGCLCs17. In all reported
cases of xenotransplantation, human and nonhuman primate
germ cells do not differentiate into haploid sperm in the mouse
seminiferous tubule niche. Instead, they recapitulate many of the
characteristics that are unique to male germline stem cells. These
include the ability to (1) migrate to the basement membrane of
seminiferous tubules, (2) divide to produce chains of cells with
spermatogonial characteristics (a high nuclear to cytoplasmic
ratio and intercellular bridges), and (3) persist for long periods of
time.
In order to confirm that the testicular xenotransplantation
bioassay could be used as an important reporter for germline
competency despite the lack of apparent differentiation, Hermann
and colleagues18,19 showed that homologous transplantation of
rhesus macaque testicular cells into recipients depleted of sper-
matogonial stem cells prior to transplantation promotes
spermatogenesis from donor cells16,20. Furthermore, not only
were the donor SSCs competent to undergo complete sperma-
togenesis the donor-derived sperm were competent to fertilize
rhesus macaque oocytes and give rise to donor-derived
embryos20. It is unknown how less mature rhesus macaque
germ cell types will respond in this assay.
In the current study, we differentiated riPSCs to early (VASA
negative) rPGCLCs that we characterize as being similar to bona
fide embryonic rPGCs younger than 28 days of embryo devel-
opment post-fertilization. Following xenotransplantation into
irradiated nude mice or homologous transplantation into irra-
diated rhesus macaques, we show that the seminiferous tubules
environment supports the survival of rPGCLCs and promotes
further differentiation to a VASA-positive state. Taken together,
transplantation to the seminiferous tubule environment promotes
rPGCLC differentiation beyond what can currently be achieved
in vitro.
Results
Rhesus PGCLCs equate to rPGCs younger than embryonic day
28. To date, all directed differentiation strategies to generate
primate PGCLCs create VASA negative cells equivalent to early-
stage PGCs1,2. In the cynomolgus macaque, VASA protein
expression is induced in cynoPGCs at around Carnegie Stage
(CS) 12 (Days 26–30)6. To evaluate this in rhesus macaque
embryos, we collected time-mated CS12 rhesus embryos (n= 3)
(Fig. 1a). Examination of transverse histological sections in the
region of the aorta–gonad–mesonephros (Fig. 1a, box), revealed
gonadal ridge epithelium, (Fig. 1b, arrow-heads), but no definitive
gonad. Immunofluorescence (IF) staining for the transcription
factor SOX17, a classical visceral endoderm marker that is also
required for hPGC specification1 revealed that SOX17 positive
cells can be found in the dorsal aorta (DA), the mesonephros (m),
the genital ridge epithelium (white arrow-heads), and the dorsal
mesentery (white arrow) (Fig. 1c). IF staining of the transcription
factor TFAP2C, a second marker of primate PGCs, revealed that
TFAP2C positive cells are restricted only to the dorsal mesentery
and the genital ridge epithelium (Fig. 1d, box and arrow), and not
the DA. Therefore, the DA SOX17 positive cells are most likely
the hemogenic endothelium21. This also indicates that TFAP2C is
a discriminating marker of primate PGCs in this region of the
embryo at this developmental stage6. Triple IF staining of SOX17,
TFAP2C, and the transcription factor PRDM1, all markers of
early PGCs, identifies triple positive rPGCs in the dorsal
mesentery, as well as rPGCs closely associated with the gonadal
ridge epithelium (Fig. 1d). Furthermore, all TFAP2C positive
rPGCs in CS12 co-express the pluripotent transcription factor
OCT4 (Fig. 1e). To determine whether rPGCs at CS12 corre-
spond to early rPGCs (VASA negative) or late rPGCs (VASA
positive)6, we stained for VASA and the rPGC marker TFAP2C.
Our data indicate that the majority of CS12 rPGCs were located
in either the dorsal mesentery or the genital ridge epithelium, and
the majority of TFAP2C positive rPGCs were also VASA positive
(Supplementary Figure 1a, b). In addition, rare VASA negative
TFAP2C positive cells were also identified (Fig. 1e, white arrows).
As expected SOX2 was not expressed in any TFAP2C positive
rPGCs (Fig. 1e).
Once we determined that the antibodies raised against
TFAP2C, SOX17, PRDM1, OCT4, and VASA (Supplementary
Table 1) could discriminate rPGCs in the embryo, we next
examined the expression of these proteins with differentiation of
riPSCs into rPGCLCs. The rPGCLC differentiation strategy
involved a modification5 of the two-step differentiation protocol
first described by Sasaki and colleagues2. The first step involves
harvesting undifferentiated riPSCs cultured on mouse embryonic
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fibroblasts (MEFs) as a single cell suspension followed by
differentiating the riPSCs for 24 h to create incipient
mesoderm-like cells (iMeLCs) (Fig. 2, Supplementary Figure 2a).
The second step involves differentiating the iMeLCs as three-
dimensional aggregates in low adhesion 96-well plates (Fig. 2a).
Rhesus PGCLCs are formed in step 2 within the aggregates in
response to bone morphogenetic protein 4 (BMP4). In the first
experiment, we used IF to test whether the transcription factors
SOX17, PRDM1, or TFAP2C are expressed in undifferentiated
riPSCs, or iMeLCs prior to aggregate differentiation. We also
examined the expression of BRACHYURY (BRA) to confirm
iMeLC induction, as well as pluripotency transcription factors
OCT4 and SOX2. We found that both riPSCs and riMeLCs
expressed OCT4 and TFAP2C, and in addition, riMeLCs also
expressed BRA as expected2. SOX2 was uniformly expressed in
riPSCs and heterogeneously in iMeLCs. Importantly, we found
that riPSCs, and iMeLCs did not expressed SOX17 or PRDM1
(Supplementary Figure 2b, c). Therefore, we hypothesize these
transcription factors could be used together to document the
emergence of nascent rPGCLCs in the aggregate.
To identify rPGCLCs, aggregates were assessed at Day (D) 1 to
D4 for SOX17 and PRDM1 expression. SOX17/PRDM1 double
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Fig. 1 Identification of rPGCs by immunofluorescence using early and late rPGC markers. a CS12 rhesus macaque embryo. Box highlights the region that
was assessed for migrating rhesus Primordial Germ Cells (rPGCs) Scale bar, 1 mm. b Transverse histological section of CS12 embryo reveals the genital
ridge epithelium (arrowheads) Scale bar, 400 µm. c Immunofluorescence (IF) staining of CS12 sections showing SRY-box 17 (SOX17, blue) and DAPI
nuclear stain (white) in genital ridge epithelium (white arrowheads), adjacent mesonephros (m) dorsal mesentery (white arrow), or hemogenic
endothelium (yellow arrowhead) within the dorsal aorta (DA). Scale bar, 200 µm. d IF staining of AP-2 gamma (TFAP2C, green) can discriminate rPGCs
(box) in the dorsal mesentery (arrow) as well as the genital ridge epithelium (arrowhead) of a CS12 embryo. Triple IF staining of PR/SET domain 1 (PRDM1,
red), SOX17 (blue), and TFAP2C (green) can be used to mark rPGCs (dotted circles) (merge, white; DAPI nuclear stain, gray). Scale bar, 200 µm. e Dual IF
for TFAP2C (red) confirms co-expression with the germ cell marker OCT4, SOX17, and VASA. Yellow arrow-heads indicate TFAP2C/VASA double
positive rPGCs. White arrowheads indicate TFAP2C positive VASA negative rPGCs. SOX2 (green) is not expressed in rPGCs. Merged images show DAPI
nuclear stain (blue). Scale bars, 15 µm. n= 3 CS12 embryos, shown are images from Day (D) 28
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positive cells were identified starting on D1 through D4 with only
a rare single positive cells (Supplementary Figure 3a). Previous
studies analyzing cyno embryos at the time of lineage specifica-
tion identified SOX17/PRDM1 double positive cells as marking
both cynoPGCs as well as visceral endoderm (VE) cells6.
Therefore, to discriminate between these two possibilities in the
aggregates, we also stained SOX17 together with TFAP2C, which
is positive in cynoPGCs while being negative in VE6. Double IF
staining of aggregates revealed that subpopulations of SOX17
positive cells were also TFAP2C positive at D1, with more double
positive cells emerging from D2 (Supplementary Figure 3b).
Based upon the SOX17/TFAP2C dual staining results, we
examined rPGCLC formation by using the triple stain to identify
cells co-expressing PRDM1/SOX17/TFAP2C in the aggregates.
Using this approach, we discovered triple positive rPGCLCs as
early as D1 of aggregate differentiation in two independent lines
of riPSCs (riPSC89 and riPS90) (Fig. 2b and Supplementary
Figure 3c). These triple positive rPGCLCs persisted through D4
and up to D8 (Fig. 2b and Supplementary Figure 3c). However, by
D15 of aggregate differentiation, triple positive rPGCLCs were
undetectable in either riPSC line (Supplementary Figure 3c–e).
Given that TFAP2C may be expressed earlier in the rhesus
macaque relative to hPGCs, we quantified the total percent of
TFAP2C positive cells from D1 to D4 of aggregate differentiation,
and discovered that TFAP2C positive cells are a minor fraction of
the total aggregate at each time point (Fig. 2c). Furthermore,
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Fig. 2 Specification of rPGCLCs from riPSCs. a Schematic overview of rPGCLC-specification in aggregates via an iMeLC intermediate. Scale bars= 100 µm,
shown are images of riPSC89 differentiation. b Triple IF staining for germ cell markers during riPSC89 aggregate differentiation from Day (D) D1 through
D4. PRDM1 (red), SOX17 (blue), TFAP2C (green), DAPI (gray). Dotted lines highlight TFAP2C positive cells (single and clusters). Scale bars, 50 µm. N= 3
biological replicates. c The percent of TFAP2C positive cells (green) in aggregates at D1–D4. d The percent of TFAP2C positive cells in aggregates at D1–D4
that are either single (TFAP2C, green), double (TFAP2C/PRDM1, red or TFAP2C/SOX17, blue), or triple (TFAP2C/PRDM1/SOX17, black) positive for early
rPGC markers. Shown are results using the riPSC90 cell line, unless otherwise stated
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TFAP2C positive cells were mostly triple positive at all time
points (TFAP2C together with SOX17 and PRDM1). However
TFAP2C/SOX17 double positive cells were clearly identified
notably at D1–3 whereas TFAP2C/PRDM1 double positive cells
were never identified (Fig. 2d). Taken together, our results
indicate that triple positive PRDM1/SOX17/TFAP2C rPGCLCs
are induced at D1 of aggregate differentiation, and that the
potential rPGCLC precursors are either SOX17/TFAP2C or
SOX17/PRDM1 double positive but not TFAP2C/PRDM1.
Rhesus macaque PGCLCs arrest before epigenetic reprogram-
ming. To identify the transcriptional identity of rPGCLCs, we
isolated rPGCLCs using fluorescence activated cell sorting
(FACS) at D1, 2, 4, and 8 of aggregate differentiation using
antibodies that recognize EPCAM and ITGA6 (Fig. 3a). EPCAM
and ITGA6 were chosen because they were previously used to
recognize hPGCLCs in aggregate differentiation2. The frequency
of EPCAM/ITGA6 double positive cells was highest in D2
aggregates, while at D4, this population stabilized at around 9.5%.
On D8, the percent of EPCAM/ITGA6 ultimately constitutes only
a small fraction of all cells in an aggregate (Fig. 3a). Using real-
time polymerase chain reaction (PCR) to detect rPGC markers
NANOS3, TFAP2C, PRDM1, and cKIT, we show that the rPGCLC
genes are all up-regulated in the EPCAM/ITGA6 double positive
population compared to undifferentiated riPSCs and riMeLCs
(Fig. 3b).
To determine whether rPGCLCs are in the early or late stages
of rPGC development, we examined VASA expression using IF at
D4 and D8 and discovered that all TFAP2C positive rPGCLCs in
aggregates are VASA negative (Fig. 3c). In contrast, late rPGCs at
CS12 (D28) and CS23 (D50) are VASA positive (Fig. 3c).
Prior to the transitioning from early to late, cynoPGCs undergo
global loss of 5-methyl cytosine (5mC)6; to examine this, we
performed IF using antibodies that recognize 5mC together with
OCT4 to identify rPGCLCs/rPGCs. OCT4 positive rPGCs at
CS12 (D28) and CS23 (D50) are negative for 5mC as expected
(white circles). In contrast, rPGCLCs at D2, D4, and D8 of
aggregate differentiation are all positive for 5mC (Fig. 3d). This
result suggests that in aggregates, the rPGCLCs have not
undergone global DNA methylation reprogramming as detected
using IF. In addition to 5mC, we also evaluated 5-
hydroxymethylcytosine (5hmC), which is dynamically enriched
in the mPGC genome during mPGC migration and genital ridge
colonization23–26. In the rhesus embryos at CS12 (D28), we
discovered that rPGCs were positive for 5hmC, albeit at low levels
and similar to somatic cells of the embryo. In contrast at CS23
(D50), the rPGCs and most somatic cells were 5hmC negative. In
the aggregates, all rPGCLCs were 5hmC positive (Fig. 3e). Taken
together, rPGCLCs generated in vitro correspond to SOX17/
TFAP2C/PRDM1 newly specified rPGCs that have not initiated
global 5mC/5hmC epigenetic reprogramming as monitored by IF.
Xeno- and homologous transplantation promote differentia-
tion. Previously, it was reported that CS23 rPGCs xeno-
transplanted into the seminiferous tubules of the busulfan-treated
mouse testicles colonize the seminiferous tubule basement mem-
brane giving rise to colony-like chains of cells17. To determine
whether rPGCLCs persist in this assay and form colonies, we first
created a green fluorescent protein (GFP) expressing subline of
riPSC89 using a lentivirus (referred to as riPSC89UbiC:GFP). Prior
to transplantation, karyotype analysis was performed to confirm a
normal 42XY male karyotype27. The riPSC89UbiC: GFP line was
differentiated through the two-step protocol ending at D8 of
aggregate differentiation. The D8 aggregates were shipped over-
night on cold packs to MD Anderson Cancer Center in Houston
where they were dissociated and xenotransplanted into the
seminiferous tubules of adult immune-deficient nude mice that
had been irradiated to ablate endogenous spermatogenesis. The
recipient mouse testes were seeded with between 5.0 × 104 and
1.3 × 105, unsorted aggregate cells per transplant (n= 6 testicles).
As a control, we also transplanted 1.9 × 105–2.7 × 105 undiffer-
entiated riPSCs per transplant (n= 6 testicles). Eight weeks after
transplant the mice were euthanized, and the testicles were
analyzed.
At the time of dissection, 6/6 recipient testicles receiving a
single cell suspension of aggregate cells were GFP positive. In
contrast, only 4/6 recipient testicles that received undifferentiated
riPSCs were GFP positive (Supplementary Figure 4a). This result
is consistent with previous reports that single cell suspensions of
undifferentiated primate pluripotent stem cells exhibit poor
survival, which our data would suggest extends to the
seminiferous tubule environment. Whole mount IF of the GFP
positive testicles using the non-human primate (Nhp), anti-
rhesus macaque testis cell antibodies18 followed by
AlexaFluor488 secondary antibodies demonstrated that the
Nhp/GFP positive cells in the recipient testicles that received
aggregates were VASA positive indicative of rPGCLC differentia-
tion. In contrast, the recipient testicles that received undiffer-
entiated riPSCs were VASA negative (Fig. 4a). Histological
analysis of the GFP positive recipient testicles xenotransplanted
with donor aggregates sometimes revealed cysts (4/6) (Supple-
mentary Figure 4b–e, asterisk) but, did not form teratomas. In
contrast, testicles transplanted with riPSCs yielded teratomas in 2
out 4 of cases.
To confirm that xenotransplantation supported rPGCLC
differentiation, sections of testicles were processed to paraffin
and sections stained for VASA together with the spermatogonial
stem cell markers MAGEA4 and ENO2. Using these markers, we
show that almost all Nhp positive rPGCLCs in the recipient
mouse testicular tubules differentiate into VASA positive germ-
line cells confirming the results of the whole mount. Furthermore,
these Nhp-positive germline cells were exclusively located on the
basement membrane, typical of spermatogonia. A fraction (28%)
of NHP positive rPGCLCs also expressed the spermatogonial
protein MAGEA4 (Fig. 4b). In contrast, ENO2 was not expressed
in any Nhp-positive cells (n= 15) in the mouse testis (Fig. 4b).
Due to the finding that only one of the spermatogonial stem
cell markers (MAGEA4) was expressed in xenotransplanted
donor rPGCLCs, we hypothesized that the rPGCLCs may not
correspond to adult-stage spermatogonia and instead the
MAGEA4 single positive germ cells may represent an earlier
stage of primate germ cell development. To address this, we
stained human fetal testis at 17 weeks post-fertilization and found
ENO2/MAGEA4 double positive hPGCs (hPGCs were identified
with VASA) (Supplementary Figure 4f). In contrast, at earlier
embryonic points (D28 and D50), MAGEA4 was expressed in
VASA positive rPGCs whereas ENO2 was not (Supplementary
Figure 4g). Given that MAGEA4 and ENO2 were not expressed
in rPGCLCs before xenotransplantation (Supplementary Fig-
ure 4g), our results support the hypothesis that xenotransplanta-
tion results in rPGCLC differentiation into VASA/MAGEA4
positive rPGCLCs corresponding to a stage in embryo develop-
ment prior to ENO2 positive spermatogonial differentiation.
To confirm that the rPGCLCs originated from the specified
rPGCLCs in the aggregates and not de novo specification of
rPGCLCs donor aggregate cells while in the seminiferous tubules,
we used FACS to isolate EPCAM/ITGA6 positive (rPGCLCs) and
negative (somatic) cells, and xenotransplanted the two populations
separately into the testicles of irradiated SCID mice (Supplementary
Figure 4h). Using confocal microscopy of intact testicles, we
identified GFP-positive signal only in the testicles xenotransplanted
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with FACS isolated rPGCLCs but not in testicles xenotransplanted
with somatic cells or sham control (no donor cells) (Supplementary
Figure 4h). This result suggests that the rPGCLCs in the
xenotransplant differentiated from the rPGCLCs originally specified
in the aggregates, which subsequently underwent further differ-
entiation following xenotransplantation.
Based on the induction of MAGEA4 and VASA in the
xenotransplanted donor cells, the expectation is that the colonized
rPGCLCs should also have initiated epigenetic reprogramming. To
address this, we transplanted a single cell suspension of D4
aggregates from the riPSC90 line into busulfan-treated nude mice
and examined enrichment of 5mC and 5hmC using IF. Given that
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Fig. 3 rPGCLCs in aggregates correspond to early rPGCs prior to global 5mC erasure. a FACS plots showing the percent of EPCAM/ITGA6 double positive
cells in undifferentiated riPSC89 (neg control), and riPSC89 aggregates at Day (D) 1, 2, 4, and 8. b RT-PCR analysis show enrichment of early rPGC
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(red) indicate that the late-stage rPGC marker VASA (green) is not expressed in rPGCLCs at D4 or D8 and instead is expressed in rPGCs in CS12 (D28)
and CS23 (D50). Scale bars, 20 µm. d IF staining showing 5mC (green) is present in OCT4-positive(+) (red) rPGCLCs in aggregates (dotted white line) at
D2, D4, and D8, while being absent from OCT4+ (red) rPGCs (dotted white line) in CS12 (D28) and CS23 (D50) embryos. Scale bars, 20 µm. e IF staining
of 5hmC (green) in OCT4+ (red) rPGCs (dotted white line) at CS12 (D28) as well as in OCT4+ (red) rPGCLCs (dotted white line) in D2, D4, and D8
aggregates. CS23 (D50) rPGCs (OCT4+, red) do not have detectable 5hmC (green). Scale bars, 20 µm. Shown are results using riPSC90 unless otherwise
stated. N= 3 biological replicates for riPSCs and CS12 (D28); n= 2 biological replicates for CS23 (D50)
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riPSC90 was not labeled with GFP, the donor rPGCLCs were
identified using an antibody that detects the primate-specific,
nuclear mitotic apparatus protein (NuMA). This result shows that
the NuMA positive rPGCLCs undergo global loss of 5mC (Fig. 5a).
To detect 5hmC in these xenotransplants, we performed sequential
IF staining of adjacent sections, and show that NuMA positive
rPGCLCs are also 5hmC positive (Supplementary Figure 5a–d).
Therefore, this result supports the hypothesis that xenotransplanta-
tion induces rPGCLC differentiation to the equivalent of late-stage
of rPGCs in the middle of epigenetic reprogramming similar to
those identified at CS12, but younger than those at CS23 where
5hmC and 5mC are no longer detectable by IF.
Given that the loss of 5hmC in mPGCs occurs largely through
replication-coupled demethylation, we were also interested in
determining whether rPGCs are in cycle during this develop-
mental window. To achieve this we stained for the nuclear
antigen Ki67 in rhesus embryos at CS12 (D28) and CS23 (D50) as
well as aggregates at D4 and D8 (Fig. 5b). In all cases, the
rPGCLCs/rPGCs were identified using IF for TFAP2C (red) with
Ki67 labeled in green. The results are quantified as the percentage
of Ki67 positive cells in the TFAP2C positive or negative
population (Fig. 5c). During aggregate differentiation, the
TFAP2C positive rPGCLCs at D4 are mostly Ki67 negative (not
in cycle), whereas the somatic cells are Ki67 positive. In contrast
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at D8, the majority of somatic cells are Ki67 negative, whereas
50% of the rPGCLCs are now in cycle and are Ki67 positive. In
the embryo, rPGCs at D28 and D50 are almost Ki67 positive and
therefore in the cell cycle during 5mC/5hmC epigenetic
reprogramming. Analysis of the xenotransplants shows that the
majority of NuMA positive donor cells (red) are Ki67 negative
and therefore the rPGCLCs are not in cycle following
xenotransplantation (Fig. 5d). Taken together, our data indicate
that xenotransplantation induces rPGCLC differentiation and
epigenetic remodeling, however the adult testicular niche causes
the rPGCLCs to exit the cell cycle before completing epigenetic
reprogramming and global removal of 5hmC.
Due to the inability of primate cells to fully reprogram and
differentiate to ENO2 positive spermatogonia in the mouse
testicular niche, we next tested the hypothesis that homologous
transplantation of aggregates into irradiated rhesus macaque male
testicles could remove the barrier to rPGCLC differentiation.
Therefore, we transplanted dissociated aggregates containing
rPGCLCs or undifferentiated riPSCs into the left and right testis,
respectively, of rhesus macaque males depleted of germ cells by
irradiation (n= 2). The monkeys were also administered GnRH-
antagonist treatment starting immediately after irradiation for
2 months until the time of transplantation. GnRH-antagonist
treatment is expected to facilitate survival and colonization of
transplanted cells16. Serum testosterone levels were monitored to
confirm transient suppression of testosterone during GnRH
antagonist treatment and maintenance of Leydig cell function
after irradiation (Fig. 6a). Ultrasound-guided rete testis injection
was performed under general anesthesia to transplant 4.2 million
single aggregate cells, and 9.8 million undifferentiated riPSCs into
the rete testis. Following transplantation, testicular volumes and
serum testosterone were measured monthly in each animal
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(Fig. 6a). In animal 9-174, the final volume and weight of
recipient testicles at 7 months after transplantation were
indistinguishable from each other, despite one testicle receiving
aggregate cells, whereas the other testicle received undifferen-
tiated riPSCs. In contrast, in the other animal (animal number 9-
052), the testicle transplanted with undifferentiated riPSCs was
11-fold heavier relative to the contra-lateral testicle transplanted
with aggregate cells (Fig. 6a).
Given the abnormal growth of the testicle in animal 9-052 that
received undifferentiated iPSCs, the experiment was terminated at
7 months after transplant, and the testicles from both animals
were removed. Upon dissecting the testicles from animal 9-052, it
was apparent under visual inspection that the testicle receiving
aggregate cells contained cysts, whereas the testicle that received
undifferentiated riPSCs was filled with solid tumorigenic masses
(Supplementary Figure 6a, 6b). It was also possible to identify
GFP positive signal in both testicles from 9-052 (Supplementary
Figure 6c). Histological analysis confirmed that transplantation of
undifferentiated riPSCs resulted in the formation of a teratoma in
animal 9-052, which had almost completely invaded the testicle
(Fig. 6b).
In order to determine whether rPGCLCs generated MAGEA4/
ENO2 positive spermatogonial stem cells, the testicles from 9-174
and 9-052 were fixed, embedded, and serially sectioned. Using
GFP to mark the transplanted cells, we identified rare GFP
positive cells along the seminiferous tubule basement membrane
of rhesus macaque testicles injected with aggregates (2/2
transplants of aggregates) (Fig. 6d, e) that resulted in the
formation of colonies (Fig. 6f). In contrast, the GFP-positive
testicle transplanted with undifferentiated riPSCs exhibited no
colonies (Fig. 6f). The GFP positive cells did not represent
complete spermatogenesis, and instead were organized as
individual cells, and occasionally pairs. Moreover, we show that
the GFP positive cells along the basement membrane were
positive for VASA and MAGEA4 but were negative for ENO2
(Fig. 6g–i). Control rhesus macaque seminiferous tubules
confirmed antibody specificity for VASA, MAGEA4, and ENO2
(Fig. 6j). Taken together, these findings confirm homologous
transplantation of aggregates containing rPGCLCs leads to
differentiation into VASA positive, MAGEA4 positive cells,
however the adult testicular niche does not support differentia-
tion into ENO2 positive spermatogonia.
Discussion
Here, we establish the rhesus macaque as another non-human
primate species amendable to rPGCLC differentiation in vitro.
Consistent with previous studies in the human1,2 and in the
cynomolgus macaque4, VASA RNA and protein are not detected
in rPGCLCs during aggregate formation28. VASA is an evolu-
tionary conserved gene that is expressed in germline cells of all
metazoan, and in mammals is expressed as PGCs approach the
developing genital ridge6,29,30. In the current study, we show that a
genital ridge is not necessary to induce VASA protein expression
in rPGCLCs, and instead VASA protein can be induced following
xeno or homologous transplant into an adult testicular niche.
The mechanism responsible for inducing VASA protein in
mammalian PGCs is unclear. Using transgenic mouse technology,
ectopic expression of mouse vasa homologue (mvh) in somatic
cells can be achieved by the global loss of DNA methylation31. In
the current study, our data show that differentiation into VASA-
positive rPGCLCs is accompanied by a global loss of 5mC.
Therefore, we hypothesize that the expression of VASA in
rPGCLCs is associated with DNA methylation reprogramming
following xenotransplantation. Given that rPGCLCs are lost
between D8 and D15 of aggregate differentiation in vitro, we
propose that it is the transfer of rPGCLCs to a new environment
supportive of rPGCLC survival that is primarily responsible for
triggering global DNA demethylation and advancing differentia-
tion into VASA-positive cells. Consistent with this, the culture of
mPGCs/mPGCLCs in growth factors and chemicals that main-
tain mPGC survival also enable the transition to MVH-positive
state without a requirement for testicular cells32,33. Therefore, it is
likely that adult testicular cells per se are not responsible for
inducing VASA expression. Given this result, we anticipate that
chemically defined conditions could be identified in the future to
support the differentiation of rPGCLCs without the requirement
for transplantation.
The markers MAGEA4 and ENO2 were originally chosen as an
approach to examine rPGCLC differentiation to adult sperma-
togonial stem cells following xenotransplantation. Given the lack
of ENO2 expression in MAGEA4 positive transplant-derived
rPGCLCs, we hypothesized that MAGEA4 may be marking an
earlier stage of germ cell differentiation when ENO2 is negative.
Here, we show that MAGEA4 is expressed much earlier in rhesus
germ cell development, being present in VASA positive rPGCs at
CS12 as they approach the genital ridge epithelium, as well as in
VASA positive rPGCs at CS23. In contrast ENO2 is not expressed
in rPGCs at these stages, instead being expressed together with
MAGEA4 and VASA in putative pro-spermatogonia. It is difficult
to predict whether the lack of ENO2 in the transplant-derived
rPGCLCs is due to a block in developmental timing, or whether
ENO2 is abnormally silenced. However, failure to also erase
5hmC in the xenotransplant-derived rPGCLCs, together with exit
from the cell cycle is consistent with a block in developmental
timing such that the transplanted rPGCLCs are arresting in
development and exiting the cell cycle at a stage equivalent to
rPGCs younger than CS23.
Previous studies showed that testicular xenotransplantation of
undifferentiated hESCs and hiPSCs into the testicles of busulfan-
treated nude mice causes differentiation into VASA positive
hPGCLCs accompanied by teratoma, embryonal carcinoma, and
yolk sac tumor formation34. The tumors in previously published
studies most likely originate from hiPSCs/hESCs because testi-
cular xenotransplantation of embryonic testicles containing bona
fide hPGCs results in colony formation without tumorigenesis17.
Unlike studies using human pluripotent stem cells, we did not
identify any evidence of VASA positive putative rPGCLCs in the
testicles transplanted with undifferentiated riPSCs. The under-
lying reason for this discrepancy is unclear and may be due to
species-specific differences in the donor cells (human verse
rhesus).
Successful resumption of spermatogenesis from donor cells in
homologous monkey-to-monkey transplants involves the transfer
of tissues containing adult spermatogonia18,20. In the current
study, the lack of spermatogenesis in homologous transplants
could be due to either an incompetent rPGCLC or alternatively
the possibility that rPGCLC/rPGCs are incapable of differentiat-
ing in an adult niche. In support of the young verses old niche
hypothesis, mouse transplantation studies using neonatal infertile
recipients can support spermatogenesis from mPGCs, whereas
adult infertile recipients can support spermatogenesis from pro-
spermatogonia or spermatogonia9. Given this, the only way to
experimentally test whether rPGCs have the competency to fully
differentiate into haploid sperm in an adult niche would be to
perform homologous transplants of bona fide rPGCs into infertile
rhesus recipients at different ages (from neonate to adult). The
feasibility of this theoretical experiment is challenged by the very
low numbers of rPGCs found during the embryonic stages of
interest.
In summary, we show that rPGCLCs differentiated in aggre-
gates are competent to differentiate into VASA/MAGEA4
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positive rPGCLCs capable of epigenetic reprogramming and
global loss of 5mC when transplanted into an adult testicular
niche. However, our data also indicate that transplantation into
the adult niche is associated with rPGCLCs exiting from the cell
cycle before the loss of 5hmC can be completed. Given an
equivalent stage of rPGCLC differentiation was achieved in
homologous and xenotransplants, our studies also suggest that
testicular xenotransplantation may be a cost-effective option for
testing lineage commitment of in vitro specified primate PGCLCs
prior to conducting costlier, and time-consuming non-human
primate, autologous or homologous transplantation experiments.
Although it is well known that full reconstitution of spermato-
genesis cannot be achieved in the mouse from non-human pri-
mate cells, our study highlights the similarities when either mice
or monkeys are used as recipients of in vitro differentiated
rPGCLCs.
Methods
Time-mated breeding of rhesus macaque. Time-mated breeding of rhesus
macaque males and females was performed by measuring estradiol daily in the
female starting from D5 to D8 after menses began17. Pregnancy was confirmed by
measuring progesterone as well as by ultrasound. Embryos at CS12 were collected
by C-section (n= 3 at D28, n= 1 at D26, n= 1 at D30). All rhesus macaque time-
mated breeding experiments were conducted following the approval of the Oregon
National Primate Research Center (ONPRC) Institutional Animal Care and Use
Committee (IACUC).
Maintenance and directed differentiation of riPSC lines. Undifferentiated
riPSC8927 and riPSC9022 cells were cultured on a feeder layer of mitomycin C-
treated MEFs in hESC media (DMEM/F-12) (Life Technologies), 20% KSR (Life
Technologies), 10 ng/mL bFGF (R&D Systems), 1% nonessential amino acids (Life
Technologies), 2 mM L-glutamine (Life Technologies), Primocin™ (Invivogen), and
0.1 mM β-mercaptoethanol (Sigma). Media was changed daily and colonies were
passaged manually every 5 days. For iMeLC inductions we followed previously
published protocols with minor modifications2,5. Briefly, D5 riPSCs colonies were
trypsinized (0.05% trypsin) (Life Technologies), resuspended in MEF media. The
MEFs were depleted by plating the cell suspension in tissue culture dishes, two
times, for 5 min each. The resulting cell suspension was pelleted and resuspended
in iMELC media (GMEM) (Life Technologies), 15% KSR (Life Technologies),
0.1 mM nonessential amino acids (Life Technologies), penicillin/streptomycin/L-
glutamine (Life Technologies), Primocin™ (Invivogen), 0.1 mM β-mercaptoethanol
(Sigma), sodium pyruvate (Life Technologies), activin A (PeproTech), CHIR99021
(Stemgent), Y-27632 (Stemgent), filtered through a 40 µm cell strainer (Falcon) and
plated at a density of 1.0 × 105 cells per well of a human plasma fibronectin
(Invitrogen)-coated 12-well plate. After 24 h of incubation at 37 °C with 5.0% CO2,
iMeLCs were trypsinized (0.05% trypsin, Life Technologies) and resuspended in
PGCLC media (GMEM) (Life Technologies), 15% KSR (Life Technologies),
0.1 mM nonessential amino acids (Life Technologies), penicillin/streptomycin/L-
glutamine (Life Technologies), Primocin™ (Invivogen), 0.1 mM β-mercaptoethanol
(Sigma), sodium pyruvate (Life Technologies), 10 ng/mL human LIF (EMD Mil-
lipore), 200 ng/mL BMP4 (R&D Systems), 50 ng/mL EGF (Fisher Scientific), 10 µM
Y-27632 (Stemgent), and plated at a density of 3.0 × 103 cells per well of a low
adherence spheroid forming 96-well plate (Corning). Aggregates were collected for
analysis on Days 1, 2, 3, 4, 8, and 15 of directed PGCLC differentiation.
Human fetal samples. Human prenatal testes were acquired following elected
termination and pathological evaluation after UCLA-IRB review which deemed the
project exempt under 45 CRF 46.102(f). All prenatal testes were obtained from the
University of Washington Birth Defects Research Laboratory (BDRL), under the
regulatory oversight of the University of Washington IRB approved Human Sub-
jects protocol combined with a Certificate of Confidentiality from the Federal
Government. BDRL collected the fetal testes and shipped them overnight in HBSS
with an ice pack for immediate processing in Los Angeles. All consented material
was donated anonymously and carried no personal identifiers. Developmental age
was documented by BDRL as days post-fertilization using a combination of pre-
natal intakes, foot length, Streeter’s Stages, and crown-rump length. All prenatal
gonads documented with a birth defect or chromosomal abnormality were
excluded from this study.
Immunofluorescence (IF) staining. Aggregates containing rPGCLCs were col-
lected and then fixed in 4% PFA and embedded in histogel (Thermo Scientific) to
facilitate subsequent embedding into paraffin blocks. Sections of aggregates, rhesus
embryos, or human fetal tissues (5 µm) placed onto microscope slides were then
de-paraffinized and rehydrated through a xylene, ethanol series. For antigen
retrieval, slides were heated to 95 °C in Tris-EDTA solution (10 mM Tris Base,
1 mM EDTA solution, 0.05% Tween-20, pH 9.0). Sections were permeabilized
(PBS, 0.05% Triton-100) and then blocked in PBS containing 10% normal donkey
serum. The primary antibodies anti-5mC (AMM99021; 1:100), anti-5hmC (39769;
1:100), anti-5hmC (51660S; 1:100), anti-OCT4 (sc8628x; 1:100), anti-OCT3/4
(sc5279; 1:100), anti-TFAP2C (sc12762; 1:200), anti-TFAP2C (sc8977; 1:200), anti-
PRDM1 (9115S; 1:100), anti-SOX17 (GT15094; 1:100), anti-SOX2 (MAB2018;
1:100), anti-VASA (AF2030; 1:100), anti-Brachyury/T (AF2085; 1:200), anti-
MAGEA4 (Clone 57B; 1:30), anti-ENO2 (MMS-518P; 1:500), anti-Ki67 (556003;
1:200), anti-NuMA (Ab84680; 1:200) (Supplementary Table 1) were incubated
overnight at 4 °C. This was then followed by incubating the slides for 60 min at
room temperature with their corresponding, species-specific, secondary antibodies:
donkey anti-mouse IgG AF488 (715-546-150; 1:500), donkey anti-rabbit IgG
AF488 (A21206; 1:500), donkey anti-goat IgG AF488 (705-546-147; 1:200), goat
anti-mouse IgG2a AF488 (A21131; 1:200), donkey anti-goat IgG AF594 (705-586-
147; 1:200), donkey anti-mouse IgG2b AF594 (A21145; 1:200), donkey anti-rabbit
IgG AF594 (711-585-147; 1:500), donkey anti-mouse IgG AF594 (A21203; 1:200),
donkey anti-goat IgG AF647(A21447; 1:200), donkey anti-rabbit IgG AF647
(A31573; 1:500) (Supplementary Table 1). Mounting media (Prolong-gold anti-
fade w/DAPI, Invitrogen) was added and slides were sealed. Slides were allowed to
cure for at least 24 h at 4 °C prior to imaging.
riPSCs and riMeLCs were plated onto culture slides (Corning) and grown
overnight in their respective media, at 37 °C with 5.0% CO2. Cells were washed
with PBS then fixed in 4% PFA for 10 min. Cells were rinsed with PBST and then
permeabilized (PBS, 0.05% Triton-100) for 10 min. Nonspecific binding was
blocked (PBS, 10% normal donkey serum for 30 min) and then incubated
overnight at 4 °C with primary antibodies (Supplementary Table 1). Species-
specific secondary antibodies were added to slides and incubated at room
temperature for 1 h. Mounting media was added, slides were sealed, and then cured
for 24 h.
Mouse testes tissues were fixed overnight in 4% paraformaldehyde, 5 µm thick
paraffin sections were used for the immunofluorescence study. The monkey testes
were fixed in cold 4% paraformaldehyde overnight, processed through a sucrose
gradient, and then embedded in OCT compound; 8 µm cryosections were cut for IF
staining. For testicular histology of both mouse and monkey, Bouin’s or 4%
paraformaldehyde-fixed tissues were embedded in paraffin and sections were
stained in periodic acid-Shiff’s-hematoxylin.
For fluorescent immunostaining, either the deparaffinized or frozen sections
were subjected to antigen retrieval by initially heating in boiling citrate buffer
(BioGenex) for 2 min followed by cooling for 30–60 min. The slides were rinsed
and blocked in antibody diluent. Subsequently, sections were stained with the
following primary antibodies in antibody diluent: goat anti-VASA (AF2030; 1:100),
mouse anti-ENO2 (MMS-518P; 1:500), mouse anti-MAGE-A4 (Clone 57B, kindly
provided by Dr. Giulio Spagnoli, University Hospital Basel, Switzerland; 1:30),
rabbit anti-GFP (2956S; 1:100), rabbit anti-rhesus testis cell (NHP) (provided by
Kyle Orwig; 1:200). For double immunofluorescent staining, the two primary
antibodies incubated with the tissue sections were detected with species-specific
secondary antibodies (Supplementary Table 1). Stained sections were mounted
with VectaShield mounting media containing DAPI (Vector Laboratories) and
imaged. Positive immunoreactivity was validated by the omission of primary
antibody and testing the antibody in a tissue in which it is known to be positive.
Microscopy. Confocal images of the riPSC89 line, riPSC90 line, iMeLCs, and
sectioned aggregates were examined on an LSM 880 (Carl Zeiss) with a Plan-
Apochromat 20×/0.8 NA and a Plan-Apochromat 63×/1.4 NA M27 oil immersion
objective at room temperature. Acquired images were processed using IMARIS 8.1
(Bitplane). H&E slides were examined on an Olympus BX-61 light microscope.
Images were processed with Image J version 1.51d (NIH). D28 embryos, teratomas,
and cysts images were stitched together using the grid-stitching plugin in Image J
version 1.51d (NIH).
For immunofluorescence imaging of tissue sections or whole mounts of
seminiferous tubules, a Leica DM 4000B (Leica Microsystems) microscope was
used.
Image analysis. Quantification of confocal images was performed using IMARIS
8.1 (Bitplane) microscopy image analysis software. To quantify the total percent of
cells that were positive for TFAP2C in D1, D2, D3, and D4 aggregates, we first
quantified the total number of nuclei using the spot detection function to detect
DAPI. Only DAPI positive nuclei that overlapped with TFAP2C signals were
counted, using the IMARIS spot function. Using the TFAP2C channel and the co-
localization function in IMARIS we built co-localization channels for SOX17 and
PRDM1 channels. Through this strategy, we were able to quantify single, double,
and triple positive cells found in aggregates using the IMARIS spot function. Three
random sections were counted for each sample for Days 1–4 of differentiation and
these experiments were repeated on two separate cell lines (riPSC89 and riPSC90)
with at least 2 technical replicates each. Graphs were made using Prism 7 (Graph
Pad) data analysis software.
To quantify the total percent of cells that were positive (+) for Ki67, first we
counted the total number of nuclei using the spot detection function to detect
DAPI. Next, utilizing TFAP2C to demark germ cells we built a co-localization
channel for Ki67. The spot function was used on the newly built co-localization
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channel to quantify the number of cells that were both positive for TFAP2C and
Ki67. To quantify the number of somatic cells that were Ki67+, we counted the
total number of cells that were positive for Ki67 and subtracted from the total
number of Ki67+ germ cells (TFAP2C+). Three random fields were counted for
each sample with 3 replicates each for Days 1–4 of differentiation. Graphs were
made on Prism 7 (Graph Pad) and error bars represent the standard error of the
mean.
Fluorescence activated cell sorting analysis of rPGCLCs. The rPGCLCs at D1,
D2, and D4 were dissociated using 0.05% trypsin, while D8 PGCLCs were dis-
sociated using 0.05% trypsin and Collagenase IV. Cells were washed with MEF
media and then re-suspended in FACS buffer. Dissociated cells were incubated
with anti-ITGA6-BV421 (BioLegend 313624; 1:50) and EPCAM-PE (Life Tech-
nologies A15782; 1:50) antibodies. Double positive cells were collected using an
ARIA-H Fluorescence Activated Cell Sorter. Cells were sorted into RLT buffer and
stored at −20 °C until ready to isolate RNA. Sorts of rPGCLCs were performed on
at least 2 replicates for each group. Cytometry analysis was performed using
FlowJo™ version 10.
Establishment of the riPSC89UbiC:GFP reporter line. The riPSC89 GFP-reporter
line was established through episomal delivery of the lentivirus GFP-IRES_PUR-
O_cassette, a kind gift from Dr. Zoran, using lipofectamine 3000 (Invitrogen).
Karyotypes performed by Cell Line Genetics (Madison, WI) indicated that the
GFP-expressing riPSC89 line had a normal karyotype.
Whole mount immunofluorescence of seminiferous tubules. For quantitative
analysis of donor rhesus testis cell colonization, intact seminiferous tubules were
prepared from nude mouse recipient testes, collected 8 weeks after transplanta-
tion16. Donor-derived colonies of spermatogonia were detected in intact semi-
niferous tubules by whole mount immunofluorescent staining with the rhesus testis
cell antiserum18. Samples were dehydrated stepwise in methanol and then incu-
bated in MeOH:DMSO:H2O2 (4:1:1) for 2 h. The rhesus testis-cell antibody was
used and detected with rabbit secondary antibodies (Supplementary Table 1).
Samples were mounted with Vectashield medium containing DAPI (Vector
Laboratories) on slides with raised coverslips and visualized by fluorescence
microscopy.
In co-staining experiments, the rhesus testis cell and VASA antibodies were
detected with species-specific antibodies (Supplementary Table 1).
RT-PCR. Purified RNA was extracted from undifferentiated riPSCs, riMeLCs, and
D6 rPGCLC sorted cells (EPCAM/ITAG6) using the RNAeasy mini kit (Qiagen).
RNA was converted to cDNA using Superscript II Reverse Transcriptase (Invi-
trogen). Gene expression analysis was performed using the following gene
expression assays: TFAP2C: Rh02844868_m1 (Applied Biosystems); PRDM1:
Rh02837836_m1 (Applied Biosystems); KIT: qMccCIP0023334 (BioRad);
NANOS3: qMccCEP0031201 (BioRad); GAPDH: qMccCIP0038690 (BioRad).
Context sequences for the probes used were provided by the manufacturer and are
as follows:
TFAP2C:
GCGATTGTTTTGGGGGACGCCGGACGCCATGTTGTGGAAAATAACTGA
TAATGTCAAGTACGAAGAGGACTGCGAGGATCGCCACGACGGGAGCAG
CAATGGAAATCCGCGAGTCCCCCACCTCTCCTCCGCCGGGCAGCACCTC
TACAGCCCCGCGCC
PRDM1:
CGCCAAGGTGCGCGTCTGTACGGCTCAGCCCGGCGGGGGACGCGGGGA
GAATGTGGACTGGGTAGAGATGAGCGAGACTTTTCTCAGATGTTGGA
TATTTGCTTGGAAAAACGTGTGGGTACGACCTTGGCTGCCCCCAAGTG
TAGCTCCAGCACTGTGAGGTTTCAGGGATTGGCAGAGGGGACCAAGGG
GACCATGAAAATGGACATGGAGGATGCGGATATGACTCTGTGGACAGA
GGCTGAGTTTGAAGAGAA
KIT:
TAGTCAACGTTGCCTGACGTTCATAATTGAAGTCACCGTGATGCCAGC
TATTATATTTCTCCTGTAGTTTAGTCTGACTGTTTTCTCTTTTCCACGTT
GAGTACACAGAACTAGACACATCTTTTATTGTGCATGTCACTG
NANOS3:
TCATCGGTCCCAGTGCCAGGATCCAAGGATCAGAAGCGCAGCCTGGAG
TCCTCGCCAGCTCCCGAACGCCTGTGCTCTTTCTGCAAACACAACGGCG
AGTCCCGGGCCATCTACCAGTCCCACGTGCTGAAGGACGAGGC
GAPDH:
GAGACACCATGGGGAAGGTGAAGGTCGGAGTCAACGGATTTGGTCGTA
TTGGGCGCCTGGTCACCAGGGCTGCTTTTAACTCTGGTAAAGTGGATA
TTGTTGCCATCAATGACCCCTTCATTGACCTCAACTACATGGTTTACAT
GTTCCAGTATGATTCCACCCATGGCAAGTTCCATGGCACCGTGAAGGCT
GAGAACGGGAAGCT
Xenotransplantation into the seminiferous tubules. A single cell suspension of
D8 aggregates (0.1 mg/mL Collagenase, Type IV (Gibco)) and then 0.05% trypsin
(Gibco) and undifferentiated riPSCs (0.1 mg/mL Collagenase, Type IV (Gibco))
were created prior to xenotransplantation. The single cell suspension was injected
in the right and left testicles of nude mice depleted of germ cells by irradiation
using a 137Cs gamma-ray unit. The radiation was delivered as an initial 1.5-Gy dose
and followed by a second dose of 12 Gy35,36. About 7 µL of solution (a range of
5.4 × 104–2.7 × 105 cells) was injected per testicle12. Mice were allowed to recover
and sacrificed 2 months later. In most cases, testicles were fixed in 4% paraf-
ormaldehyde, paraffin-embedded and sectioned for IF analysis. In some cases,
seminiferous tubules were dispersed using collagenase and DNase, fixed in 4%
paraformaldehyde and prepared for the whole mount IF staining. For injection of
riPS90 into busulfan-treated nude mice, a 7 µL solution of aggregate cells (7.0 ×
105–8.0 × 104 cells) was injected into the rete testes according to previously pub-
lished approaches17. For transplantation of FACS isolated riPSC89UbiC:GFP
rPGCLCs, mice were irradiated as above, and 1.1 × 103 rPGCLCs isolated by FACS
for ITGA6/EPCAM at D4 of aggregate differentiation were xenotransplanted into
each recipient testicle together with a single cell suspension of irradiated mouse
testicular carrier cells (3.0 × 104). For somatic cells, the ITGA6/EPCAM double
negative cells at D4 were transplanted into irradiated male mice as above with a
1.3 × 103–1.1 × 104 cell range. Mouse transplantation studies using irradiated nude
mice were approved by The University of Texas M.D. Anderson Cancer
Center Animal Care and Use Committee. Mouse transplantation studies performed
on busulfan-treated nude mice were approved by the IACUC committees of
Magee-Womens Research Institute and the University of Pittsburgh School of
Medicine.
Homologous transplantation into monkey seminiferous tubules. Day 8
rPGCLCs aggregates (0.1 mg/mL Collagenase, Type IV (Gibco) and then 0.05%
trypsin (Gibco)) and riPSCs (0.1 mg/mL Collagenase, Type IV (Gibco)) were
dissociated prior to transplantation. Both rPGCLCs and riPSCs were suspended in
MEMα containing 10% FBS, trypan blue (0.4 mg/mL; Sigma-Aldrich), 20% (v/v)
Optison ultrasound contrast agent (GE Healthcare, Waukesha, WI, USA), 1%
antibiotic–antimycotic (a combination of penicillin, streptomycin, and amphoter-
icin B; Gibco) and DNase I (0.1 mg/mL) in a total volume of 0.5 mL. Using
ultrasound guidance, to locate the rete testis, riPSCs were injected into the right
testis and rPGCLC to the left testis of Rhesus macaques depleted of germ cells by
testicular irradiation with 7 Gy16. Either 9.8 million riPSCs or 4.2 million rPGCLCs
were injected per testis. To possibly enhance the grafting of the transplanted cells,
the monkeys were given hormone suppression treatment using a GnRH-antagonist
Acyline (obtained from the Contraceptive Development Program of the NICHD,
Rockville, MD, USA) for 2 months starting immediately after irradiation and until
the time of transplantation16. To prevent T cell-mediated rejection of the grafted
cells, transplant recipients were treated with human/mouse chimeric anti-CD154
IgG 5C8 (NIH Nonhuman Primate Reagent Resource, University of Massachusetts
Medical School, Boston, MA) at 20 mg/kg on Days −1, 0, 3, 10, 18, 28, and
monthly thereafter. Changes in testes sizes and serum testosterone levels were
monitored during the post-transplantation period and the testes were harvested
7 months after transplantation. The sliced testes were fixed in 4% paraformalde-
hyde and after initial observation under fluorescence scope for any GFP signal, they
were either embedded in OCT and cryosectioned for immunofluorescence analysis,
or embedded in paraffin for histology. All rhesus macaque transplantation studies
were approved by The University of Texas M.D. Anderson Cancer Center Animal
Care and Use Committee.
Data availability
All relevant data are included in the paper and/or its Supplementary Information
files and are available from the authors. A Reporting Summary for this Article is
available as a Supplementary Information file.
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